Neumora Therapeutics, Inc. Common Stock ( NMRA) - Stock Earnings
NMRA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -59.5 million USD | — USD |
| 2026Q1 | -53.5 million USD | — USD |
| 2026Q2 | -43.1 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
NMRA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -235.9 million USD | — USD |
| 2024 | -243.8 million USD | — USD |
| 2025 | -236.9 million USD | — USD |
| 2026 Est. | — | — |
NMRA
Price: $1.51
52 week price:
Earnings Per Share: -1.23 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 308.1 million